Philip Hashkes, M.D.

Philip Joseph Hashkes, MD, MSc, was born in New York and moved to Israel. In 2003, he was recruited to Cleveland Clinic as the Head of the Section of Pediatric Rheumatology. He is also an Associate Professor of Medicine and Pediatrics at the Lerner College of Medicine at Case Western Reserve University.

He has practiced pediatric rheumatology since 1994 and his major clinical interests include the new and expanding field of autoinflammatory (“periodic fever”) diseases, pediatric vasculitis and the drug therapy of juvenile arthritis, especially the new “biologic” medications.

He has been named in America’s “Best Doctors” list and is the pediatric consultant for the Vasculitis Foundation. A major part of his work is devoted to the research of new treatment for juvenile arthritis and autoinflammatory diseases and to epidemiologic studies of the long-term outcome of these diseases.

He has received research grants from the Arthritis Foundation and the Food and Drug Administration. He has recently started working at the National Institutes of Health (NIH) autoinflammatory research clinic as part of Cleveland Clinic-NIH partnership. He is a member in several national and international organizations devoted to the research of pediatric rheumatology and is a member of the Medical and Scientific Committee of the local chapter of the Arthritis Foundation.

He has published more than 55 scientific papers and book chapters in pediatric rheumatology and is a frequent lecturer in local and national medical meetings. His paper describing evidence-based guidelines for the medical treatment of juvenile arthritis is considered of the most important papers on this topic in recent years. He is currently the pediatric rheumatology section editor of the Current Opinion in Rheumatology journal.

• Cleveland Clinic-National Institutes of Health (NIH) partnership to work with the NIH in their autoinflammatory (periodic fever) research clinic
• 2005 listing by the Arthritis Foundation and American College of Rheumatology of the most important pediatric rheumatology research papers on evidence-based guidelines for the medical treatment of juvenile idiopathic arthritis
• Editor, Section of Pediatric and Hereditary Diseases, Current Opinion in Rheumatology

• Master's Degree (MSc) in epidemiology, University of Cincinnati

Pediatric rheumatology; drug therapy of arthritis; autoinflammatory (periodic fever), syndromes, pediatric vasculitis.

• Best Doctors in America Listing
• FDA federal grant for IL-1 Trap treatment of familial Mediterranean Fever (FMF)
• Arthritis Foundation grant for study of mortality outcomes in pediatric rheumatology

• American College of Rheumatology
• American Academy of Pediatrics - Rheumatology Section
• Childhood Arthritis and Rheumatology Research Alliance (CARRA)
• Pediatric Rheumatology Collaborative Study Group (PRCSG)

Cleveland Clinic physicians and scientists report if they have any collaborations with the pharmaceutical or medical device industries as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 7/31/2008, Dr. Hashkes has reported no financial relationship with industry that is applicable to this listing. Patients should feel free to contact their doctor about relationships with industry and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)